Loading...

Extended results of the Alzheimer disease anti-inflammatory prevention trial (ADAPT)

BACKGROUND: Epidemiologic evidence suggests that non-steroidal anti-inflammatory drugs (NSAIDs) delay onset of Alzheimer’s dementia (AD), but randomized trials show no benefit from NSAIDs in symptomatic AD. ADAPT randomized 2,528 elderly persons to naproxen or celecoxib vs. placebo for two years (s....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Breitner, John C, Baker, Laura D, Montine, Thomas J, Meinert, Curtis L, Lyketsos, Constantine G, Ashe, Karen H, Brandt, Jason, Craft, Suzanne, Evans, Denis E, Green, Robert C, Ismail, M Saleem, Martin, Barbara K, Mullan, Michael J, Sabbagh, Marwan, Tariot, Pierre N.
Format: Artigo
Sprog:Inglês
Udgivet: 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3149804/
https://ncbi.nlm.nih.gov/pubmed/21784351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2010.12.014
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!